Open AccessBroad application prospects of bone turnover markers in pediatrics
Author(s) -
Zhang Yiduo,
Huang Xiaocui,
Li Chao,
Zhang Jing,
Yu Xingnan,
Li Ye,
Zhou Wenjie,
Yu Fan
Publication year - 2022
Publication title -
journal of clinical laboratory analysis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.536
H-Index - 50
eISSN - 1098-2825
pISSN - 0887-8013
DOI - 10.1002/jcla.24656
Subject(s) - bone remodeling , osteocalcin , n terminal telopeptide , medicine , bioinformatics , procollagen peptidase , type i collagen , bone age , pediatric endocrinology , physiology , endocrinology , biology , biochemistry , alkaline phosphatase , enzyme
Background Bone turnover markers (BTMs) have been studied for application in clinical medicine. However, BTMs in children are challenging, and few studies explore these BTMs in children. The application of BTMs is complicated mainly due to pre‐analytical factors, variable reference intervals of age‐ and sex‐related BTMs for adolescents and children in different regions and laboratories. Therefore, laboratory testing of BTMs is critical for understanding pediatric bone development and metabolism, which provides additional information about bone development and diseases. Methods Literature search was conducted using the MeSH term “child” combined with the terms that bone turnover markers such as “osteocalcin,” “Procollagen type I N‐terminal propeptide,” “procollagen type I C‐terminal propeptide,” “osteocalcin,” “N‐terminal cross‐linked telopeptide,” and “C‐terminal cross‐linked telopeptide,” Several databases including Web of Science, Google Scholar, and PubMed were searched to obtain the relevant studies. Results BTMs represent the combined effects of skeletal development, growth, and remodeling in children, which can be used in clinical pediatrics to assist in the diagnosis and prognosis of bone metabolic disorders. Conclusion BTMs are clearly helpful for diagnosis and monitoring of bone growth and development as well as bone metabolic disorders.